Health & Fitness:Medicine
In this episode of the IJGC podcast, Editor-in-Chief Dr. Pedro Ramirez is joined by Dr. Flurina Saner to discuss the Fagotti Score at interval surgery in ovarian cancer. Dr. Saner, gynecologist and obstetrician, is a gynae oncology fellow at the University Hospital Inselspital Bern, Switzerland. Her research focuses on patients with ovarian cancer and clinical and molecular determinants for long-term survival.
Highlights:
- The Fagotti score after neoadjuvant treatment shows a strong correlation with resection status, progression-free and overall survival of patients with advanced ovarian cancer
- ΔFagotti – indicating the change of the score during neoadjuvant chemotherapy - tracks with outcome after neoadjuvant chemotherapy for ovarian cancer
- Fagotti scores are valuable for an individualized patient treatment planning and should be routinely assessed at time of interval debulking surgery.
- The prognostic value of the Fagotti score after neoadjuvant therapy should be further validated in a prospective study, f.e. the LANCE trial.
More Episodes
The ALICE Trial with Glauco Baiocchi Neto
2022-05-18
2022-05-18
Mentor’s Podcast: Jalid Sehouli
2022-05-09
2022-05-09
The PARCER Trial with Supriya Chopra
2022-04-19
2022-04-19
ERAS and MIS for Same-Day Discharge
2022-03-30
2022-03-30
Mentor’s Podcast: Rene Pareja
2022-03-21
2022-03-21
IJGC Special Issue 2022: Radiation Oncology
2022-03-07
2022-03-07
SUCCOR: Cone Before Radical Hysterectomy
2022-02-04
2022-02-04
Get this podcast on your
phone, FREE
